Investors
Founded in 2001 and listed on the ASX in 2015, Adherium is a respiratory eHealth company focused on patient adherence, remote medication monitoring and data management solutions for patients, payers and providers.
Due to poor adherence and compliance of inhaled medications, severe and difficult-to-treat asthma and late stage COPD patients experience frequent and severe exacerbations resulting in high healthcare costs and financial penalties for providers. With global guidelines recommending electronic adherence assessment, the accelerated adoption of remote monitoring due to COVID-19 and US reimbursement in place for remote monitoring, Adherium is well-placed to be a significant player in this changing healthcare world.
Right Time
Reimbursement in place Global Guidelines
Right Product
Cleared sensors and software with strong pipeline
Right Strategy
- Payer / Provider
- Targeted patient group
- Specialist channel partners
Right Team
Highly qualified leadership team with relevant experience
Announcements
Adherium Interactive Investor Hub
View all announcements and activity updates via our new Investor Hub! Engage with us directly by asking questions, watching video summaries and seeing what other shareholders have to say.
Stock Quote
The interactive chart below shows a historical timeline of our stock price and trading volume. Click on the tabs below to view the different timeframes
Equity Research Reports
The following equities research report on Adherium (ADR.ASX) were made available by MST Access
- MST Access Initiation Report (May 2023)
- MST Access Initiation Report (February 2023)
- MST Access Initiation Report (August 2022)
Corporate Governance
The board of directors of Adherium supports the core principles and best practice recommendations published by the ASX Corporate Governance Council. The current policies, procedures and practices of the Company as contained in its Corporate Governance Policy comply with the Council’s principles and best practice recommendations.
The Company's Corporate Governance Policy includes the following:
- Primary Board Charter
- Diversity Charter
- Securities Trading Charter
- Audit and Risk Charter
- Nomination and Remuneration Charter
- Supplementary policies (including code of conduct)
Governance Documents
Studies have shown that patients’ adherence is the primary issue for patients with COPD: “patients with underuse are at a higher risk for adherence-related morbidity” and have an increased need for emergency medication, such as the use of a rescue inhaler.1 These studies conclude that “for clinicians, it seems evident that efforts directed at improving, evaluating and measuring adherence should be a routine component of asthma care.”2
1 Restrepo, et al., Medication adherence issues in patients treated for COPD, Int. J. Chron Obstruct Pulmon Dis., 3(3): 371 384 (Sept. 2008).
2 Engelkes, et al., supra n. 4.
Investing FAQs
Where is Adherium’s principal administrative office?
Adherium Limited
Level 14
333 Collins Street
Melbourne VIC 3000
Australia
How can I invest in Adherium?
You can purchase Adherium shares through any broker or online share trading platform.
When is Adherium’s Annual General Meeting?
The AGM is typically held in November each year.
Who is Adherium’s independent auditor?
PricewaterhouseCoopers
Who are the members of Adherium’s Management team?
View the members of Adherium’s Senior Management team.
How do I contact Investor Relations with a question or request?
Contact us or email investors@adherium.com
Who do I contact about my shareholding?
Computershare Investor Services Pty Limited
Within Australia: 1300 850 505
Outside Australia: +61 3 9415 4000
What does Adherium do?
Adherium Limited is an international health technology company at the forefront of providing digital respiratory medication adherence solutions and data informatics, enabling physicians and payers to optimally manage patients with severe, uncontrolled asthma and COPD. Accelerated adoption of telehealth and remote patient monitoring and favourable reimbursement in the US, all play directly to Adherium’s strengths – and those of its strategic partners.
On what stock exchange is Adherium traded and what is the ticker symbol?
Adherium is listed on the ASX market, the primary registered securities exchange in Australia operated by ASX Limited. The ticker symbol is ADR. For most stock-tracking software, including mobile phone apps, use the symbol ADR.AX.
When does Adherium’s fiscal year end?
June 30
Who is the Company’s outside legal counsel?
K&L Gates
Who are the members of Adherium’s Executive team?
View the members of Adherium's Executive team.
Who are the members of Adherium’s Board of Directors?
View the members of Adherium's board.
Investor Enquiries
Adherium (NZ) Limited
Level 2, 63 Albert Street
Auckland 1010
New Zealand
PO Box 106612
Auckland 1143, New Zealand